Montelukast Dicyclohexylamine Salt

Also known as: Montelukast Dicyclohexylamine, Montelukast DCHA, 1-(((1(R)-(3-(2-(7-chloro-2-quinolinil)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropane acetic acid dicyclohexylamine salt, Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, compd. with N-cyclohexylcyclohexanamine (1:1), Montelukast racemate CRS, Montelukast dicyclohexylamine Impurity, Montelukast sodium impurity 8

Montelukast Dicyclohexylamine Salt (CAS 577953-88-9) is a compound in the Organic Bases category listed in the Jingsj chemical database. It has the molecular formula C47H59ClN2O3S and a molecular weight of 767.501 g/mol. Key property: a melting point of 65-67°C (lit.). No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 577953-88-9
Jingsj CID: J-1983769-5
Molecular Formula: C₄₇H₅₉ClN₂O₃S
Molecular Weight: 767.501 g/mol
Category: Organic Bases
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	65-67°C (lit.)
Exact Mass	766.393494
PSA	107.75000
LogP	12.58030
Storage Conditions	2-8°C

Activity & Biological Data

Target	CysLT1
Additional Information	[1]. Pu S, et, al. Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury. Front Pharmacol. 2019 Sep 18; 10:1070. [2]. William RHJ, et, al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 2002 Jan 1; 165(1): 108-16. [3]. Langlois A, et al. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism. J Allergy Clin Immunol. 2006;118(1):113-119. [4]. Khan AR, et al. Montelukast in hospitalized patients diagnosed with COVID-19. J Asthma. 2022 Apr;59(4):780-786.

Target

CysLT1

Additional Information

[1]. Pu S, et, al. Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury. Front Pharmacol. 2019 Sep 18; 10:1070. [2]. William RHJ, et, al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med. 2002 Jan 1; 165(1): 108-16. [3]. Langlois A, et al. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism. J Allergy Clin Immunol. 2006;118(1):113-119. [4]. Khan AR, et al. Montelukast in hospitalized patients diagnosed with COVID-19. J Asthma. 2022 Apr;59(4):780-786.

Frequently Asked Questions

What is the CAS number of Montelukast Dicyclohexylamine Salt?

The CAS number of Montelukast Dicyclohexylamine Salt is 577953-88-9.

What are the molecular formula and molecular weight of Montelukast Dicyclohexylamine Salt?

Montelukast Dicyclohexylamine Salt has molecular formula C47H59ClN2O3S and molecular weight 767.501 g/mol.

What are the upstream and downstream products of Montelukast Dicyclohexylamine Salt?

For Montelukast Dicyclohexylamine Salt, Upstream Products: Dicyclohexylamine, Montelukast, 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid; Downstream Products: Montelukast, Montelukast sodium.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Montelukast Dicyclohexylamine Salt (CAS 577953-88-9)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1983769-5 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.